Last reviewed · How we verify
Heparin Leo and Hepalean
Heparin Leo and Hepalean is a Small molecule drug developed by Southlake Regional Health Centre. It is currently in Phase 1 development. Also known as: Heparin Leo, Hepalean.
At a glance
| Generic name | Heparin Leo and Hepalean |
|---|---|
| Also known as | Heparin Leo, Hepalean |
| Sponsor | Southlake Regional Health Centre |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Heparin Leo and Hepalean CI brief — competitive landscape report
- Heparin Leo and Hepalean updates RSS · CI watch RSS
- Southlake Regional Health Centre portfolio CI
Frequently asked questions about Heparin Leo and Hepalean
What is Heparin Leo and Hepalean?
Heparin Leo and Hepalean is a Small molecule drug developed by Southlake Regional Health Centre.
Who makes Heparin Leo and Hepalean?
Heparin Leo and Hepalean is developed by Southlake Regional Health Centre (see full Southlake Regional Health Centre pipeline at /company/southlake-regional-health-centre).
Is Heparin Leo and Hepalean also known as anything else?
Heparin Leo and Hepalean is also known as Heparin Leo, Hepalean.
What development phase is Heparin Leo and Hepalean in?
Heparin Leo and Hepalean is in Phase 1.
Related
- Manufacturer: Southlake Regional Health Centre — full pipeline
- Also known as: Heparin Leo, Hepalean
- Compare: Heparin Leo and Hepalean vs similar drugs
- Pricing: Heparin Leo and Hepalean cost, discount & access